These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inhibition of follicular growth by two different oral contraceptives (monophasic and triphasic) containing ethinylestradiol and gestodene.
    Author: Lete I, Morales P.
    Journal: Eur J Contracept Reprod Health Care; 1997 Sep; 2(3):187-91. PubMed ID: 9678091.
    Abstract:
    OBJECTIVE: To evaluate the inhibition level of ovarian follicular growth produced by a triphasic oral contraceptive (OC) containing ethinylestradiol and gestodene vs. the level produced by a monophasic OC containing the same components. METHODS: A randomized, blind, cross-over trial was performed in a sample of 56 women. The follicular diameters were measured in 56 cycles under triphasic contraceptive treatment, and the other 56 under monophasic contraceptive treatment, using vaginal ultrasound. The statistical analysis was performed using the Student's t test. RESULTS: The mean follicular diameter under monophasic OC treatment was found to be 8.16 mm (standard deviation 4.5), and while under triphasic OC treatment was found to be 7.44 mm (standard deviation 2.8) (p > 0.05). In 17 out of 112 cycles (15%), a certain degree of follicular activity was found (follicular diameter more than 10 mm), 10 cycles under monophasic OC and 7 cycles under triphasic OC. CONCLUSIONS: The triphasic OC provides good inhibition of follicular growth and excellent contraceptive efficacy.
    [Abstract] [Full Text] [Related] [New Search]